Company Performance Metrics
Martin Lagod: Stakeholder BoardPast Role: Firelake Capital Management, Director and Co-Founder
Genencor International, Inc. (NASDAQ-NM: GCOR) is a diversified biotechnology company with over $350 million in 2002 revenues. Genencor focuses on two markets: bioproducts and health care. For the bioproducts market, Genencor discovers, develops and sells biocatalysts and other biochemicals for the industrial, consumer and agri-processing markets.
For the health care market, Genencor has drug development platforms in protein therapeutics and immunotherapeutics targeting viral infectious diseases and cancer.
Genencor leverages its technology platforms across both markets. These platforms include: gene discovery and functional genomics, molecular evolution and design, metabolic pathway engineering, immunology, and biomaterial production and formulation delivery systems. With many industry firsts, Genencor has shown the power of its technology by delivering innovative products to the marketplace.
